New Investor Website
OptiBiotix Health plc has launched a new interactive investor website designed to consolidate all corporate, commercial, and research content into a single platform for improved investor engagement. The website will feature announcements, reports, presentations, research publications, and direct Q&A opportunities with the management team, aiming to provide stakeholders with reliable information for investment decisions. This initiative is intended to enhance communication beyond standard RNS announcements, allowing for more in-depth discussions on commercial progress and product development, including second-generation products like SweetBiotix.
Select text to share a quote on X · sign in to keep highlights & notes in your OPTI notes
OptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes, announces the launch of a new interactive investor website. The new investor website brings all OptiBiotix content including corporate, commercial and research into a single platform to better inform and engage with prospective and existing investors and other stakeholders. The website includes:
- Announcements (RNS and Reach)
- Annual and Interim reports
- Investor presentations, podcasts and video updates
- Research publications, product and technology overviews
- Interviews with the CEO
- Interviews and videos with research/ industry partners on its technology and products
The website provides users with the ability to ask the management team questions to provide context on announcements including progress or concerns via an interactive portal which will be monitored and responded to in a timely manner. The overall aim is to give existing and prospective shareholders the opportunity to engage directly with the management team and have access to reliable information on which they can make a judgement. We would encourage all existing shareholders and prospective investors to sign up to the website (it should take less than one minute) and use it as your primary interface and information source for the business.
How to sign up for the OptiBiotix investor website:
- Visit www.optibiotix.com
- Follow the prompts on the top right-hand side of the website marked SIGN UP
- Complete your account profile (name/email)
Stephen O'Hara, Chief Executive Officer, commented:
"The Board is keen to improve communications with our shareholders and give them access to reliable information on which to make their investment decisions. This new 'InvestorHub' enables us to discuss commercial progress with partners, share development progress and launch plans for our second-generation products like SweetBiotix, in more depth and context than is possible through RNS announcements alone, while remaining fully compliant with market disclosure obligations.
We encourage all stakeholders to explore the site, engage with our content, and share their questions and feedback. Your input is invaluable as we continue refining our communication channels and building a profitable and valuable business."
Engage with the OptiBiotix management team directly by asking questions, watching video summaries and seeing what other shareholders have to say.
Navigate to our Interactive Investor website here: https://optibiotix.com/link/P2zk3P
Subscribe to the new website to get regular updates here: https://optibiotix.com/auth/signup
| OptiBiotix Health PLC Neil Davidson, Chairman Stephen O'Hara, Chief Executive We encourage all investors to share questions on this announcement via our investor website. | https://optibiotix.com/announcements |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.